Share Facebook
Crohn's Disease Forum » Books, Multimedia, Research & News » Infliximab maintains durable response and facilitates catch-up growth in luminal pediatric Crohn's disease


04-02-2015, 04:10 PM   #1
SupportiveMom
Forum Monitor
 
SupportiveMom's Avatar
 
Join Date: Mar 2013
Location: Toronto, Ontario

My Support Groups:
· Stoma
Infliximab maintains durable response and facilitates catch-up growth in luminal pediatric Crohn's disease

Infliximab maintains durable response and facilitates catch-up growth in luminal paediatric Crohn’s disease. http://www.ncbi.nlm.nih.gov/pubmed/24865777

These data demonstrate sustained effectiveness of infliximab in children and adolescents with luminal CD. Durability of response is increased by concomitant immunomodulation. Clinical response is associated with enhanced linear growth, particularly when therapy is initiated early.
__________________
Mom of 16 yr. girl w/Indeter.Colitis Sep. 2012(age 11) Nov.2012 Crohn's Sep. 2014 Crohn's Colitis, UC Nov 2015, Crohn's Feb. 2016

Ileostomy surgery July 2015

Current Meds: None!
Previous Meds: Humira, Remicade, Methotrexate, Cipro, Flagyl, Zofran, Cortifoam, 5-ASA suppository, Questran, Mezavant, EEN (Peptamen Jr. 1.5) by NG tube, Antibiotic Cocktail (Vancomycin, Metronidazole & Doxycycline), Simponi, Prevacid, Imuran, prednisone
ibdsupportivmom.wordpress.com ☆
Reply

Crohn's Disease Forum » Books, Multimedia, Research & News » Infliximab maintains durable response and facilitates catch-up growth in luminal pediatric Crohn's disease
Thread Tools


All times are GMT -5. The time now is 09:01 PM.
Copyright 2006-2017 Crohnsforum.com